Products

Propeller Health
Propeller Health
Patient Engagement & Education
Propeller Health, a ResMed company, provides an FDA-cleared digital health platform with smart inhaler sensors and mobile apps to track medication usage, offer personalized insights, and enable remote monitoring for asthma and COPD management.

See all 1 product →

About Propeller Health

Propeller Health is a leading digital health company dedicated to improving the management of chronic respiratory diseases, specifically asthma and Chronic Obstructive Pulmonary Disease (COPD). Their FDA-cleared platform utilizes small, custom-built sensors that attach to a patient’s existing inhaler, seamlessly connecting via Bluetooth to a smartphone application and a dedicated clinician insights portal. This integrated system automatically tracks critical medication usage data, including the time, location, and frequency of doses, and delivers personalized feedback and educational content directly to patients.

For healthcare professionals, the Propeller platform provides objective, real-world insights into patient adherence and disease control, accessible through a secure provider portal or via integration with Electronic Health Record (EHR) systems. This capability empowers clinicians to remotely monitor patient populations, proactively identify individuals at higher risk of exacerbations, and make data-driven decisions to optimize treatment strategies. Clinical studies have demonstrated that the Propeller system can significantly enhance medication adherence, reduce the reliance on rescue inhalers, and decrease asthma- and COPD-related emergency department visits and hospitalizations, thereby improving patient quality of life and contributing to lower healthcare costs.

What Physicians Need to Know

Specialized Focus
Propeller Health specializes in digital health and therapeutics for chronic respiratory diseases, primarily asthma and Chronic Obstructive Pulmonary Disease (COPD). Their platform is designed to empower individuals with these conditions to better manage their health.
FDA-Cleared Digital Therapeutics
The company offers an FDA-cleared and CE-marked digital therapeutic platform that includes small, custom-built sensors attaching to existing inhalers, a mobile app for patients, and a clinician insights portal. These sensors are compatible with over 80% of inhaled medications on the U.S. market.
Clinically Validated Outcomes
Propeller Health's solutions are clinically proven to improve medication adherence (up to 58%), reduce rescue inhaler use (up to 78%), increase symptom-free days (up to 50%), and decrease asthma- and COPD-related emergency room visits and hospitalizations (up to 57%).
AI-Powered Insights & Remote Monitoring
The platform leverages AI and machine learning (utilizing AWS services like Amazon SageMaker and Redshift) to provide personalized health forecasts based on factors like local weather and medication use. It enables remote monitoring of medication adherence, symptom patterns, and environmental triggers.
Seamless EHR Integration
Propeller Health's platform integrates with leading Electronic Health Record (EHR) systems, including Epic and Cerner (via Redox), streamlining workflows for providers and allowing real-time patient data to be accessible within their native clinical systems.
Physician Tip

For physicians, Propeller Health offers a powerful tool to enhance chronic respiratory disease management. The real-time data on medication adherence and rescue inhaler use, directly integrated into EHRs, provides actionable insights for timely interventions and personalized treatment adjustments. This can lead to earlier identification of exacerbations, improved patient outcomes, and reduced hospitalizations. The streamlined enrollment process and remote monitoring capabilities also significantly reduce administrative burden and allow for a more comprehensive view of patient health outside of clinic visits. Consider leveraging the platform for patients struggling with adherence or those at high risk for exacerbations to optimize their care plans and support value-based care initiatives.

Propeller Health places a strong emphasis on interoperability, offering robust integrations with major EHR systems such as Epic and Cerner, often facilitated through platforms like Redox. This ensures seamless data flow from patient sensors and apps directly into the physician's workflow, minimizing the need for separate portals and reducing administrative overhead. The platform also utilizes an open API (Propeller Health's Air) for integrating environmental data, further enriching the insights available to clinicians.

Products by Propeller Health

1 product in the directory

Propeller Health
Propeller Health
Patient Engagement & Education
Propeller Health, a ResMed company, provides an FDA-cleared digital health platform with smart inhaler sensors and mobile apps to track medication usage, offer personalized insights, and enable remote monitoring for asthma and COPD management.

What the Web Says

Propeller Health offers a digital platform with sensors and mobile apps to help individuals manage respiratory conditions like asthma and COPD. The platform tracks inhaler usage, identifies triggers, and provides personalized feedback and reminders. It has demonstrated positive clinical outcomes, including improved medication adherence and reduced emergency room visits. While product reviews are generally positive, employer reviews are mixed.

Overall: Mixed

Strengths

  • Improved medication adherence for asthma and COPD patients.
  • Reduced rescue inhaler use and increased symptom-free days.
  • Ability to track triggers and symptoms.
  • Personalized feedback and medication reminders.
  • Data can be shared with healthcare providers for better care management.
  • User-friendly app and unobtrusive sensors.

Limitations

  • Sensors may not be compatible with all inhalers.
  • Some users find the app's medication tracking too much.
  • Concerns about data privacy and the sharing of anonymized health data.
  • Employer reviews mention poor communication and lack of financial reward for exceeding expectations.
  • Some employer reviews indicate issues with job security and advancement.

Based on reviews from: Reddit, Zippia, Forbes, Digital Therapeutics Alliance, Wellfound, Indeed.com

Last updated: 2026-07-21

Videos

News, demos, and interviews about Propeller Health.

Loading videos...

Videos load interactively. If none appear, search YouTube for Propeller Health →

View all on YouTube

Press & Coverage

GlobeNewswire
Propeller Health accelerates push towards value-based care with new digital health solutions for patients, providers and health systems
Propeller Health announced new solutions in March 2022 to expand its FDA-cleared platform to more patients, providers, and health systems, including integrations with leading EHR systems and a new solution for Remote Therapeutic Monitoring (RTM). The company also updated its digital platform to improve health equity and expanded the availability of its sensor for AstraZeneca's Symbicort.
2022-03
RT - Respiratory Therapy
High Medication Adherence for Asthma Patients Using Propeller Health Solution
A randomized controlled trial published in The Journal of Allergy and Clinical Immunology: In Practice found that asthma patients using Propeller Health's solution showed a significant decline in rescue inhaler use and higher medication adherence rates compared to a control group. The study highlighted the platform's ability to increase asthma control by up to 63% and reduce emergency department visits and hospitalizations by as much as 57%.
2020-11
RT - Respiratory Therapy
FDA Clears Propeller Health Connectivity for Symbicort Inhaler
Propeller Health received FDA 510(k) clearance in May 2020 to connect patients using the Symbicort Inhaler to its digital health platform. This expands Propeller's platform, which already connects to most inhalers for asthma and COPD, and aims to improve medication adherence and reduce hospitalizations.
2020-05
MedCity News
Propeller gets green light to bundle its digital health tools with inhalers
European regulators approved the co-packaging of Propeller Health's digital health platform with Novartis' Enerzair Breezhaler inhaler in July 2020, marking the first time a digital health tool will be prescribed alongside an inhaled asthma medication. This collaboration aims to make digital therapeutics more accessible and convenient for patients.
2020-07
Propeller Health (via GlobeNewswire)
Orion and Propeller Health partner to bring new digital medicines to people with asthma and COPD
Orion Corporation and Propeller Health announced a partnership in February 2019 to connect Orion's Easyhaler line of inhalers to Propeller's digital medicine platform. This collaboration will expand Propeller's presence in Europe and aims to improve medication adherence and reduce the burden of asthma and COPD.
2019-02
PR Newswire
Digital Medicine Data Shows Asthma Assessment Guidelines Are Outdated, According to Propeller Health Study
New research from Propeller Health, published in The Journal of Allergy and Clinical Immunology: In Practice in October 2018, suggests that clinical guidelines for assessing asthma control need updating to incorporate objective patient information from digital medicines. The study, in partnership with the University of Colorado School of Medicine, demonstrated that digital sensors provide a more accurate view of medication use compared to patient-reported data.
2018-10
PR Newswire
Propeller Health Raises Strategic Investment from McKesson Ventures
Propeller Health announced a strategic investment from McKesson Ventures in June 2018, adding to a previous $20 million funding round. This investment will support the development of connected medicines for chronic respiratory diseases and expansion into new therapeutic areas.
2018-06
PR Newswire
Propeller Health Raises $20 Million, Accelerating Development of Digital Medicines for Respiratory Health and Other Diseases
Propeller Health secured $20 million in funding in May 2018, led by Aptar Pharma, to accelerate the development of digital therapeutics for respiratory health and expand into new disease areas. The funding will also support investment in their connected device pipeline.
2018-05

Frequently Asked Questions

Propeller Health offers a digital therapeutic platform for asthma and COPD, utilizing small sensors that attach to inhalers and pair with a mobile app to automatically track medication use. The platform uses machine learning to synthesize this data, providing personalized insights to patients and enabling clinicians to understand usage patterns, predict exacerbations, and remotely monitor patient conditions.
Propeller Health's platform and sensors are FDA-cleared and CE-marked digital therapeutics for asthma and COPD, holding multiple 510(k) clearances for various inhalers. These clearances signify formal review and adherence to medical device quality and software controls. While specific HIPAA statements were not detailed in the provided information, as an FDA-cleared medical device integrated into health systems, it operates under regulated frameworks that necessitate robust data privacy and security measures.
Propeller Health's revenue model is primarily based on partnerships with pharmaceutical companies, payers, and health systems, meaning there is typically no direct cost to the patient. Budget impact analyses suggest the platform can be cost-saving for commercial and Medicare payers due to reductions in hospitalizations and emergency department visits.
Propeller Health provides a comprehensive program including sensors, a mobile app, a web portal, and personalized support for eligible patients. Healthcare providers can utilize the Propeller Provider Portal for remote patient monitoring and receive notifications, with EHR integration streamlining data flow and enabling timely interventions.
Propeller Health has established significant partnerships with major health systems like UC Davis Health and Dignity Health, as well as with payers and pharmacy benefit managers. They also collaborate with pharmaceutical companies such as GSK, Boehringer Ingelheim, AstraZeneca, and Aptar Pharma to integrate their technology with various inhaler devices.
Propeller Health was acquired by ResMed, a global leader in cloud-connected medical devices and out-of-hospital SaaS solutions, for $225 million in early 2019. Propeller Health continues to operate as a standalone business within ResMed's Respiratory Care portfolio, indicating strong backing and continued operational focus.
Propeller Health's solutions are clinically validated, with studies demonstrating significant improvements in medication adherence, increased symptom-free days, and reductions in emergency room visits and hospitalizations for asthma and COPD patients. The platform has been evaluated in over 150 peer-reviewed studies and articles.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.